Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.
Abnormal energy regulation may significantly contribute to the pathogenesis of obesity, diabetes mellitus, cardiovascular disease, and cancer. For rapid control of energy homeostasis, allosteric and posttranslational events activate or alter activity of key metabolic enzymes. For longer impact, transcriptional regulation is more effective, especially in response to nutrients such as long chain fatty acids (LCFA). Recent advances provide insights into how poorly water-soluble lipid nutrients [LCFA; retinoic acid (RA)] and their metabolites (long chain fatty acyl Coenzyme A, LCFA-CoA) reach nuclei, bind their cognate ligand-activated receptors, and regulate transcription for signaling lipid and glucose catabolism or storage: (i) while serum and cytoplasmic LCFA levels are in the 200 mircroM-mM range, real-time imaging recently revealed that LCFA and LCFA-CoA are also located within nuclei (nM range); (ii) sensitive fluorescence binding assays show that LCFA-activated nuclear receptors [peroxisome proliferator-activated receptor-alpha (PPARalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha)] exhibit high affinity (low nM KdS) for LCFA (PPARalpha) and/or LCFA-CoA (PPARalpha, HNF4alpha)-in the same range as nuclear levels of these ligands; (iii) live and fixed cell immunolabeling and imaging revealed that some cytoplasmic lipid binding proteins [liver fatty acid binding protein (L-FABP), acyl CoA binding protein (ACBP), cellular retinoic acid binding protein-2 (CRABP-2)] enter nuclei, bind nuclear receptors (PPARalpha, HNF4alpha, CRABP-2), and activate transcription of genes in fatty acid and glucose metabolism; and (iv) studies with gene ablated mice provided physiological relevance of LCFA and LCFA-CoA binding proteins in nuclear signaling. This led to the hypothesis that cytoplasmic lipid binding proteins transfer and channel lipidic ligands into nuclei for initiating nuclear receptor transcriptional activity to provide new lipid nutrient signaling pathways that affect lipid and glucose catabolism and storage.
Schroeder
Friedhelm
F
Department of Physiology and Pharmacology, Texas A&M University, TVMC, College Station, TX 77843-4466, USA. fschroeder@cvm.tamu.edu
Petrescu
Anca D
AD
Huang
Huan
H
Atshaves
Barbara P
BP
McIntosh
Avery L
AL
Martin
Gregory G
GG
Hostetler
Heather A
HA
Vespa
Aude
A
Landrock
Danilo
D
Landrock
Kerstin K
KK
Payne
H Ross
HR
Kier
Ann B
AB
D000818:Animals; D050556:Fatty Acid-Binding Proteins / Q000235:genetics / Q000502:physiology*; D005227:Fatty Acids / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology*
D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear